Guest Editor(s)
-
- Prof. Jifeng Guo
- Department of Neurology, Xiangya Hospital, Central South University, Changsha, Hunan, China.
Website | E-mail
-
- Prof. Wei Luo
- Department of Neurology, The Second Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, Zhejiang, China.
Website | E-mail
Special Issue Introduction
Neurodegenerative diseases (NDs) are caused by the progressive loss of structure or function of neurons, with different pathophysiologies and pathogenesis. Most noteworthy, the prevalence of age-dependent neurodegenerative diseases is increasing rapidly worldwide as the population ages. However, the therapeutic options remain limited and incurable due to lack of knowledge on the mechanisms underlying the clinical manifestations. Considering the irreversible pathology and the limited treatment of neurodegenerative diseases, the capabilities of early detection and diagnosis is one of the critical issues and the only hope for a cure or prevention.
Molecular diagnostic is a collection of techniques used to analyze biological markers, improving the development of biomarker-based mechanisms or neuroprotective therapies. Molecular diagnostics also improve the early diagnosis of neurodegenerative diseases such as Alzheimer’s and Parkinson’s disease, providing the best opportunity for timely intervention and more effective medical support, even prevention.
In this special issue, we aim to discuss the multiple types of molecular diagnostics and their application in various neurodegenerative diseases.
Keywords
Molecular diagnostics, neurodegenerative diseases, Alzheimer's disease, Parkinson's disease
Submission Deadline
13 Dec 1901
Ageing and Neurodegenerative Diseases
